Federal court will allow Alzheimer's drug to stay on shelves longer

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires... To view the full story, click the title link.